← Open Payments lookup

CHRISTINE BOHLEN: Open Payments

NPI 1801293220 · MADISON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,257 in 72 payments from 23 companies in 2025. Trend: 2023 $358 · 2024 $390 · 2025 $1,257

Food & beverage: $1,257
CompanyPaymentsAmount
Novo Nordisk Inc10$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$156
ABBVIE INC.16$146
Axsome Therapeutics, Inc.6$110
AstraZeneca Pharmaceuticals LP6$104
Lundbeck LLC3$75
Bayer Healthcare Pharmaceuticals Inc.4$71
Otsuka America Pharmaceutical, Inc.3$60
Dexcom, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$33

Products named: CAPLYTA, VRAYLAR, REXULTI, Wegovy, Sunosi, Kerendia, AIRSUPRA, Ozempic.

Industry payments across GA — which companies pay providers there.